Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $811.04 | 49 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $364.47 | 24 | $0 (2024) |
| Novo Nordisk Inc | $181.05 | 10 | $0 (2024) |
| Lilly USA, LLC | $107.84 | 6 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $54.80 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $32.40 | 2 | $0 (2024) |
| Abbott Laboratories | $19.84 | 1 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $19.78 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $17.59 | 1 | $0 (2022) |
| Amgen Inc. | $13.27 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $500.34 | 31 | ABBVIE INC. ($215.23) |
| 2023 | $255.01 | 15 | ABBVIE INC. ($131.25) |
| 2022 | $55.69 | 3 | Novo Nordisk Inc ($20.11) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $3.96 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.36 | General |
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: DIABETES | ||||||
| 10/11/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Diabetes | ||||||
| 08/19/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.77 | General |
| 08/12/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Cardio-renal | ||||||
| 08/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.44 | General |
| 06/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Diabetes Care | ||||||
| 05/29/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.11 | General |
| 05/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Respiratory | ||||||
| 05/21/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: DIABETES | ||||||
| 04/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Inflammation | ||||||
| 04/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.48 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Diabetes | ||||||
| 03/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.11 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Obesity | ||||||
| 03/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.50 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 507 | 793 | $108,887 | $46,141 |
| 2022 | 5 | 111 | 133 | $14,535 | $6,609 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 110 | 277 | $52,630 | $22,892 | 43.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 105 | $14,175 | $6,541 | 46.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 15 | $10,650 | $4,243 | 39.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 38 | 38 | $6,992 | $2,733 | 39.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 18 | 18 | $4,824 | $2,111 | 43.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $3,476 | $1,656 | 47.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 92 | 169 | $4,056 | $1,420 | 35.0% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 14 | 14 | $4,060 | $1,314 | 32.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 44 | 44 | $2,156 | $1,234 | 57.2% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2023 | 20 | 23 | $2,346 | $1,156 | 49.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 15 | 15 | $750.00 | $420.75 | 56.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 27 | 28 | $1,596 | $213.08 | 13.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 16 | $976.00 | $161.62 | 16.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 16 | 20 | $200.00 | $44.00 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 54 | $7,290 | $3,424 | 47.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 16 | $3,040 | $1,417 | 46.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 17 | 17 | $2,601 | $1,165 | 44.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 20 | 20 | $980.00 | $526.60 | 53.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 23 | 26 | $624.00 | $76.44 | 12.3% |
About Dr. Adam Purvis, DO
Dr. Adam Purvis, DO is a Family Medicine healthcare provider based in Ellisville, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2019. The National Provider Identifier (NPI) number assigned to this provider is 1740740778.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adam Purvis, DO has received a total of $811.04 in payments from pharmaceutical and medical device companies, with $500.34 received in 2024. These payments were reported across 49 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($811.04).
As a Medicare-enrolled provider, Purvis has provided services to 618 Medicare beneficiaries, totaling 926 services with total Medicare billing of $52,750. Data is available for 2 years (2022–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Ellisville, MS
- Active Since 03/25/2019
- Last Updated 08/26/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1740740778
Products in Payments
- QULIPTA (Drug) $231.45
- JARDIANCE (Drug) $88.05
- MOUNJARO (Drug) $74.59
- VRAYLAR (Drug) $71.39
- UBRELVY (Drug) $43.64
- Rybelsus (Drug) $20.11
- FREESTYLE LIBRE 3 (Device) $19.84
- Kerendia (Drug) $19.78
- Wegovy (Drug) $18.10
- DALVANCE (Drug) $17.99
- BEXSERO (Biological) $17.59
- FARXIGA (Drug) $16.41
- AIRSUPRA (Drug) $15.99
- Otezla (Drug) $13.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Ellisville
Dr. Jane Gelfand, D.o, D.O
Family Medicine — Payments: $5,520
Shannon Goldsmith, D.o, D.O
Family Medicine — Payments: $4,284
William Koeppel, D.o, D.O
Family Medicine — Payments: $1,179
Joseph Danford, Md, MD
Family Medicine — Payments: $1,083
William Currie, M.d, M.D
Family Medicine — Payments: $1,017
Dr. Clarissa Allen, Md, MD
Family Medicine — Payments: $525.44